Jonathan P. Mow, Chief Executive Officer at PhaseBio Pharmaceuticals Inc (PHAS), bought 1,000 shares at $3.69 ($4K) on 2018-12-13, disclosed to the SEC on 2018-12-17.
Open-market purchase of $4k PHAS by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |